Assessing quality of life before and after transurethral resection of the prostate in benign prostatic hyperplasia...

To compare quality of life scores before and after transurethral resection of the prostate in patients with benign prostatic hyperplasia.

The prospective, observational study was conducted at the Urology Department of the Sindh Institute of Urology and Transplantation, Karachi, from September 24, 2021, to March 30, 2022, and comprised consecutive patients who were eligible to undergo transurethral resection of the prostate for benign prostatic hyperplasia. Prior to undergoing definitive surgical therapy, all the patients were evaluated using standardised questionnaires, specifically the International Prostate Symptom Score and a disease-specific quality of life score. The patients were monitored using identical questionnaires for follow-up purposes. Data was analysed using SPSS 22.

There were 50 male patients with mean age 65.08±8.33 years (range: 51-82 years). The International Prostate Symptom Score decreased significantly from 25.2±3.76 before the surgery to 8.52±1.67 after the surgery (p<0.05). The mean score for quality of life before and after the surgery was 4.62±0.67 and 1.74±0.78, respectively (p<0.05).

Transurethral resection of the prostate led to a substantial improvement in the quality of life related to urinary symptoms following benign prostatic hyperplasia treatment.